2020 Annual Meeting: March 5-7, 2020

Substance Use, Substance Use Disorders: Changing Concepts, Changing Patterns

Access Program Book

The last two decades have seen enormous changes in public perceptions, laws and policies regarding substance use and substance use disorders. During this time, alcohol and drug use has increased markedly, especially opioids, marijuana and alcohol, leading to an opioid crisis and much debate about all of these substances. Research on substance use, its antecedents and consequences has seen substantial advances, from neurofunctioning to multi-level models of policy effects. At the same time, much remains to be learned. The 2020 APPA conference will present many of these areas, including many of the major studies are now underway that promise to provide important new information in the coming years. Major advances in behavioral and pharmacologic treatments have also been made, with more to be learned and done to better disseminate effective prevention efforts, and evidence-based treatments to those in need. The conference will also cover differences in important population subgroups (women, race/ethnic group), variation by life-cycle stage, stress, psychiatric comorbidity and suicide.

Speakers include NIDA and NIAAA directors, and internationally recognized leaders and experts in the areas to be presented. The conference will provide a lively interdisciplinary forum to discuss all of these issues, as well as considering important future directions.

Deborah S. Hasin, PhD

President 2020



The American PsychoPathological Association is extremely grateful to the following generous sponsors:

Funding for this conference was made possible (in part) by 1R13DA051099-01 from the National Institute on Drug Abuse, with co-funding from the National Institute on Alcohol Abuse and Alcoholism.
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Educational Grant:
Amedco and the American Psychopathological Association would like to acknowledge the generosity of the following company whose unrestricted educational grant has contributed to the overall quality of the meeting:

Alkermes, Inc.


Thursday, March 5, 2020

8:00 AM - 5:00 PM   Registration, Broadway Foyer and Atrium

8:00 AM - 10:00 AM   Continental Breakfast, Broadway Foyer and Atrium

9:00 AM – 10:15 AM   Session 1: The View From National Institutes of Health, Broadway Ballroom Act I & II

9:00 AM - 9:10 AM   Welcoming Remarks
Deborah Hasin, PhD, Professor of Epidemiology; Columbia University

9:10 AM - 9:35 AM   The View From NIAAA
George Koob, PhD, NIAAA Director

9:35 AM - 10:00 AM   The View From NIDA
Nora Volkow, MD, NIDA Director

10:00 AM - 10:15 AM   Discussion

10:15 AM - 10:30 AM   Break

10:30 AM – 12:00 PM   Session 2: Policy, Broadway Ballroom Act I & II

Silvia Martins, MD, PhD, Associate Professor of Epidemiology, Director, Center for Policy and Health Initiatives for Opioids and Other Substances (PHIOS), Columbia University 
Chair & Discussant

10:30 AM - 10:55 AM   How can we Reverse the Tide of the Opioid Overdose Epidemic? Evidence on the Impact of Policy Solutions
Magdalena Cerdá, DrPH, MPH, Associate Professor; Director, Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine

10:55 AM - 11:20 AM   Injecting Drug Use, HIV and Syringe Service Programs; New Developments
Don Des Jarlais, PhD, Associate Director/Professor, CDUHR, NYU School of Global Public Health

11:20 AM - 11:45 AM   Observations About Cannabis Legalization, Supply and Demand
Jonathan Caulkins, PhD, Professor, Carnegie Mellon University

11:45 AM - 12:00 PM   Discussion

12:00 PM - 12:20 PM   Oral Poster Presentations, Broadway Ballroom Act I & II

12:00 PM - 12:05 PM   Parenting and Youth Cannabis Use
Alexandra Restrepo, MD, MSc, Columbia University

12:05 PM - 12:10 PM   Prefrontal Responses to Monetary Rewards and Future Substance Use
Corinne Bart, MA, Temple University

12:10 PM - 12:15 PM   Z-Drugs, Distress, Benzodiazepines, & Other Depressant Recreational Drugs
Vitor Tardelli, MD, Universidade Federal de Sao Paulo

12:15 PM - 12:20 PM   Firearm Suicide Mortality in ED Patients
Sidra Goldman-Mellor, PhD, University of California at Merced

12:20 PM - 1:20 PM   Lunch (On Your Own)

1:20 PM – 2:50 PM   Session 3: Epidemiology, Broadway Ballroom Act I & II

Charles Branas, PhD, Chair, Department of Epidemiology, Mailman School of Public Health, Columbia University
Chair & Discussant

1:20 PM - 1:45 PM   Age, Period, and Cohort Effects in Substance Use and Mental Health in the 21st Century
Katherine Keyes, PhD, Associate Professor of Epidemiology, Co-Director, Psychiatric Epi Training Program, Columbia University

1:45 PM - 2:10 PM   Breaking the Cycle of Adversity: Intergenerational Processes and Substance Use Disorders
Cristiane Duarte, PhD, Lambert Professor of Psychiatry; Director, Child Mental Health Disparities Group, Columbia University

2:10 PM - 2:35 PM   Racial Inequity in Psychiatric and Substance Use Disorders Among African Americans
Debra Furr-Holden, PhD, Mott Endowed Professor; Director, Flint Center for Health Equity Solutions, Michigan State University

2:35 PM - 2:50 PM   Discussion

2:50 PM - 3:15 PM   Presentation of the Hamilton Award
Deborah Hasin, PhD, Columbia University

3:15 PM - 3:30 PM   Break

3:30 PM – 5:25 PM   Session 4: Neurofunctioning and Genetics, Broadway Ballroom Act I & II

Diana Martinez, MD, Professor, Columbia University Department of Psychiatry
Chair & Discussant

3:30 PM - 3:55 PM   Glutamate and the Neurobiology of Human Alcoholism
John Krystal, MD, Chair, Yale University Department of Psychiatry

3:55 PM - 4:20 PM   Gender, Stress, & Substance Use Disorders
Rajita Sinha, PhD, Foundations Fund Professor; Director, Yale Interdisciplinary Stress Center, Yale University Department of Psychiatry

4:20 PM - 4:45 PM   Insights on the Genetics of Alcohol Use and Dependence From the Million Veteran Program
Joel Gelernter, MD, Foundations Fund Professor; Director, Division of Human Genetics, Yale University Department of Psychiatry

4:45 PM - 5:10 PM   Adolescent Brain & Cognitive Development (ABCD) Study
Mary Heitzeg, PhD, Associate Professor/Chair, University of Michigan

5:10 PM - 5:25 PM   Discussion

6:00 PM – 7:30 PM   Poster Session I, Broadway Ballroom Act III & IV

Friday, March 6, 2020

8:00 AM - 5:00 PM   Registration, Broadway Foyer and Atrium

8:00 AM - 9:00 AM   Continental Breakfast, Broadway Foyer and Atrium

8:00 AM – 9:30 AM Poster Session II, Broadway Ballroom Act III & IV

9:30 AM – 10:40 AM Session 5: Measurement: Diagnosis, Outcomes, Broadway Ballroom Act I & II

Edward Nunes, MD, Professor of Psychiatry, Columbia University
Chair & Discussant

9:30 AM - 9:35 AM   Presentation of the Zubin Award
Bridget Grant, PhD, Former Director, NIAAA Lab of Epidemiology

9:35 AM - 10:00 AM   Beyond Traditional Outcome Measures for SUD's
Eric Strain, MD, Professor/Director, Johns Hopkins University

10:00 AM - 10:25 AM   Meaningful Clinical Trial Endpoints
Stephanie O’Malley, PhD, Professor of Psychiatry; Director, Substance Abuse Research Division, Yale University

10:25 AM - 10:40 AM   Discussion

10:40 AM - 10:55 AM   Break

10:55 AM – 12:25 PM   Session 6: Exposure Consequences I, Broadway Ballroom Act I & II

Jill Harkavy-Friedman, PhD, Associate Professor of Clinical Psychology, in Psychiatry, Columbia University; American Foundation for Suicide Prevention
Chair & Discussant

10:55 AM - 11:20 AM   Cannabis and Psychosis
Robin Murray, MD, Professor of Psychiatry (and former Dean), Institute of Psychiatry, Kings College London

11:20 AM - 11:45 AM   Substance Use, Overdose and Suicide
Amy Bohnert, PhD, Associate Professor; Co-director, Mental Health Innovation, Services and Outcomes Program, University of Michigan

11:45 AM - 12:10 PM   Predicting Suicide Among Persons With Substance Use Disorders in the Population of Denmark
Jaimie Gradus PhD, Associate Professor, Epidemiology/Psychiatry, Boston University

12:10 PM - 12:25 PM   Discussion

12:25 PM – 1:25 PM   APPA Annual Business Meeting (Open to All Attendees)

1:25 PM - 2:15 PM   Lunch (On Your Own)

2:15 PM – 4:10 PM   Session 7: Exposure Consequences II, Broadway Ballroom Act I & II

Alan Budney, PhD, Professor, Dartmouth College
Chair & Discussant

2:15 PM - 2:40 PM   Linking Maternal Risk Traits to Specific Child Diagnoses in Fetal Alcohol Spectrum Disorders (FASD)
Philip May, PhD, Professor, Global Public Health, University of North Carolina

2:40 PM - 3:05 PM   Alcohol Stimulating and Sedating Effects
Andrea King, PhD, Professor of Psychiatry, Director, Addiction Research Laboratory, University of Chicago

3:05 PM - 3:30 PM   The Risks and Benefits of Naloxone Prescribing to Drug Users: A Randomized, Controlled Trial
Sandra Comer, PhD, Professor of Psychiatry; Director, Opioid Laboratory, Columbia University

3:30 PM - 3:55 PM   Cannabis Use Disorder: Current Perspectives
Margaret Haney, PhD, Professor of Psychiatry, Director, Cannabis Research Laboratory, Columbia University

3:55 PM - 4:10 PM   Discussion

4:10 PM - 4:25 PM   Break

4:25 PM - 4:50 PM   Presentation of the Hoch Award
Mark Olfson, MD, Professor of Psychiatry, Columbia University; Co-Director, AHRQ Center for Education & Research on Mental Health Therapeutics

4:50 PM - 5:00 PM   Discussion

Saturday, March 7, 2020

8:00 AM - 12:00 PM   Registration, Broadway Foyer and Atrium

8:00 AM - 10:00 AM   Continental Breakfast, Broadway Foyer and Atrium


8:00 AM – 9:00 AM   Early Career Investigators Round Table Breakfast, 4th Floor, Room 407

9:00 AM - 9:30 AM   Presentation of the Robins-Guze Award, Broadway Ballroom Act I & II
Sylia Wilson, PhD, Assistant Professor, Institute of Child Development, University of Minnesota

9:30 AM – 12:00 PM   Session 8: Evidence-Based Treatments and Their Dissemination, Broadway Ballroom Act I & II

John Rotrosen, MD, Professor, Department of Psychiatry, New York University
Chair & Discussant

9:30 AM - 9:55 AM   Pharmacotherapy and Pharmacogenetics of Alcohol Use Disorder
Henry Kranzler, MD, Professor of Psychiatry; Director, Center for Studies of Addiction, University of Pennsylvania

9:55 AM - 10:20 AM   Pharmacological Treatment, Opioids
Joshua Lee, MD, Associate Professor; Director, ABAM Fellowship in Addiction Medicine, New York University

10:20 AM - 10:30 AM   Discussion

10:30 AM - 10:45 AM   Break

10:45 AM - 11:10 AM   Behavioral Treatments for Substance Use Disorders
Katherine Carroll, PhD, Kent Professor of Psychiatry; Director, Psychosocial Research on Addictions, Yale University

11:10 AM - 11:35 AM   Alcohol and Other Drug Use Screening and Intervention: Efficacy, Effectiveness, Both, or Neither? 
Richard Saitz, MD, Professor and Chair, Community Health Services, Boston University School of Public Health

11:35 AM - 12:00 PM   Discussion

Meeting Concludes

APPA 2019-2020 Council


Deborah S. Hasin, PhD (Columbia University)


James Potash, MD (Johns Hopkins University)

Vice President

Kathleen Merikangas, PhD (National Institute of Mental Health)


William S. Stone, PhD (Harvard Medical School)


Joshua Breslau, ScD (RAND Corporation)

Membership Chair

Helen Wilson, PhD (Stanford University)


Jo-Ann L. Donatelli, PhD (Brown University)


Raymond DePaulo, MD (Johns Hopkins University School of Medicine)

Stephen E. Gilman, ScD (Eunice Kennedy Shriver National Institute of Child Health and Human Development)

Michael J. Lyons, PhD (Boston University) (Past President)

Susan L. Santangelo, ScD (Maine Medical Center)